Sarepta Therapeutics (SRPT)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
74.10 +0.65 (+0.88%) 03/21/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 73.82 -0.28 (-0.38%) 18:40 ET
for Fri, Mar 21st, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 235,239 | 76,190 | 42,579 | 36,119 | -535,977 |
| Depreciation Amortization | -2,553 | -6,205 | -5,396 | -3,657 | -1,779 |
| Accounts receivable | -201,661 | -34,197 | 40,330 | 21,521 | -185,699 |
| Other Working Capital | -716,606 | -591,612 | -374,989 | -184,565 | -481,089 |
| Other Operating Activity | 479,794 | 257,991 | 70,342 | -111,494 | 703,551 |
| Operating Cash Flow | $-205,787 | $-297,833 | $-227,134 | $-242,076 | $-500,993 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 100,317 | 191,879 | 261,240 | N/A |
| PPE Investments | -136,956 | -98,874 | -61,611 | -32,444 | -76,106 |
| Purchase Of Investment | -1,099,595 | N/A | N/A | N/A | -2,048,940 |
| Sale Of Investment | 2,002,112 | N/A | N/A | N/A | 1,868,482 |
| Purchase Sale Intangibles | -10,000 | -10,000 | -10,000 | -10,000 | 90,761 |
| Other Investing Activity | -10,000 | -10,000 | -10,000 | -10,000 | 90,761 |
| Investing Cash Flow | $755,561 | $-8,557 | $120,268 | $218,796 | $-165,803 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -68 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 79,525 | 75,815 | 62,058 | 22,140 | 51,246 |
| Other Financing Activity | 45,349 | 0 | 0 | 0 | 73,758 |
| Financing Cash Flow | $124,806 | $75,815 | $62,058 | $22,140 | $125,004 |
| Beginning Cash Position | 444,009 | 444,009 | 444,009 | 444,009 | 985,801 |
| End Cash Position | 1,118,589 | 213,434 | 399,201 | 442,869 | 444,009 |
| Net Cash Flow | $674,580 | $-230,575 | $-44,808 | $-1,140 | $-541,792 |
| Free Cash Flow | |||||
| Operating Cash Flow | -205,787 | -297,833 | -227,134 | -242,076 | -500,993 |
| Capital Expenditure | -136,956 | -98,874 | -61,611 | -32,444 | -76,106 |
| Free Cash Flow | -342,743 | -396,707 | -288,745 | -274,520 | -577,099 |